← Back to Search

GROW (Glioma Specialists Reaching Out With Support) Support Program for Low Grade Glioma

N/A
Waitlist Available
Led By Timothy S Sannes, PhD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial is testing a model of follow-up care for low grade glioma patients that is led by the patients and their caregivers.

Eligible Conditions
  • Low Grade Glioma
  • Survivorship
  • Caregiver Burden

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Retention Rate
Secondary outcome measures
Abbreviated Acceptability Rating Profile

Trial Design

1Treatment groups
Experimental Treatment
Group I: GROW Support ProgramExperimental Treatment1 Intervention
Patient participants will fill out questionnaires about emotional and physical health with responses used to develop an individualized survivorship plan conducted through 1x monthly virtual or in-clinic check-ins as well as GROW support meetings as needed for 6 months. Caregiver participants will fill out questionnaires used to develop patient individualized survivorship plan and participate in 1x monthly check-in meetings with patients or separately for 6 months.

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,079 Previous Clinical Trials
340,986 Total Patients Enrolled
Levitan-Zabin FundUNKNOWN
Timothy S Sannes, PhDPrincipal InvestigatorDana-Farber Cancer Institute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants being accepted into this experiment now?

"The information on clinicaltrials.gov reveals that, as of January 31st 2022, patient recruitment for this trial has been concluded. Since its initial posting on July 1st 2021 there have not been any updates to the study; however, 459 other trials are presently recruiting patients."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
GROW (Glioma Specialists Reaching Out With Support) Support
Timothy S. Sannes 2022. "GROW (Glioma Specialists Reaching Out With Support) Support". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05233215.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top